BRAF and central nervous system cancer: Firstly, BRAF-V600E mutations (valine substituted with glutamic acid at position 600) are present in gliomas including pleomorphic xanthoastrocytoma, ganglioglioma, pilocytic astrocytoma, low-grade gliomas and pediatric GBM.